New sub-project in Research Area A

01/04/2025 | News

SFB1399 continues to grow - new Junior project A10

We are pleased to announce that the SFB1399 continues to grow. Lisa Werr is our new junior group leader since April 2025 and will lead project A10 in Research Area A.

Back
SFB 1399 Mechanisms of Drug Sensitivity and Resistance in Small Cell Lung Cancer

SFB 1399 Mechanisms of Drug Sensitivity
and Resistance in Small Cell Lung Cancer

c/o Department of Translational Genomics
University of Cologne
Weyertal 115b
50931 Cologne, Germany

+49-221-478-98777
info[@]sfb1399.de

Imprint
Privacy Policy

Partners:

University of Cologne University Hospital of Cologne University Hospital Essen Max Planck Institute for Metabolism Research TRON – Translational Oncology at the University Medical Center of the Johannes Gutenberg University Main University of Bonn University of Frankfurt Deutsche Forschungsgemeinschaft CIO Centrum für integrierte Onkologie Aachen Köln Bonn Düsseldorf Lung Cancer Group Cologne